[{"Assets_0_Q3_USD":241845000.0,"CommonStockSharesOutstanding_0_Q3_shares":36807112.0,"NetIncomeLoss_1_Q3_USD":-47043000.0,"NetIncomeLoss_3_Q3_USD":-125353000.0,"StockholdersEquity_0_Q3_USD":189465000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":36779305.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":35847449.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":36779305.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":35847449.0,"Ticker":"MGNX","CIK":"1125345","name":"MACROGENICS INC","OfficialName":"MacroGenics Inc. Common Stock","form":"10-Q","period":"20170930","fy":"2017.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"504089511.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20171108"}]